October 1, 2024

Figure S8 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Los puntos clave no están disponibles para este artículo en este momento.

Potential mechanisms of palbociclib resistance in T47D and MCF7 EDR Palbo-R cell lines

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Chen et al. (Tue,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Preguntar a la IA

Me gusta

Guardar